Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06306508
Other study ID # HUvbayraktaroglu
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 16, 2024
Est. completion date February 16, 2025

Study information

Verified date March 2024
Source Halic University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Some parents may be more protective of children with CF due to concerns about worsening of the disease due to infection, which can affect their functional level. The goal of this observational study is to learn about the family's protective approach to the functioning and disease course of children with cystic fibrosis (CF) to determine whether there are possible negative effects. There will be an alternative viewpoint offered to clinicians regarding the management of CF with outputs of this study.


Description:

Cystic fibrosis (CF) is an inherited disease characterized by pulmonary involvement. Children with CF may have low levels of physical activity, physical fitness and functional capacity, and peripheral muscle weakness. Parents who take care of children with CF may be protective of their children's social environment due to reasons such as the risk of infection. Based on the idea that parents may have potential limitations on their children with CF, the aim of this study was to examine the effect of parental illness beliefs and anxiety levels on the functional and physical level of the child. Children with CF will be administered Modified Shuttle Walking Test, Munich Physical Fitness Test, quadriceps muscle strength and hand grip strength test, respiratory function and respiratory muscle strength test, Child Physical Activity Questionnaire, Shortness of Breath Beliefs Questionnaire, Revised Cystic Fibrosis Questionnaire, Parental Attitude Scale, Perceived Social Support Scale. Parents will be administered the Shortness of Breath Beliefs Questionnaire (Parent version), Revised Cystic Fibrosis Questionnaire (Parent version), Parent Attitude Scale, Fear of Disease Progression Questionnaire for Parents. The level of correlation between the outcomes of the scales administered to parents and the assessment outcomes administered to children will be examined.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date February 16, 2025
Est. primary completion date February 16, 2025
Accepts healthy volunteers No
Gender All
Age group 7 Years to 17 Years
Eligibility - Inclusion Criteria: 1. For a child 1. To be between 7-17 years old, 2. Living with family or caregiver. 2. For the parent 1. Being the mother, father or other caregiver of the child, 2. Voluntarily agreeing to participate in the study on behalf of both the child and oneself. - Exclusion Criteria: 1. For the child 1. Having cognitive impairment that would prevent participation in the study or being able to cooperate with the measurements and not being able to adapt, 2. History of previous lung or liver transplantation, 3. History of hospitalization within the last 1 month, 4. Having a neurological or orthopedic comorbidity that affects mobility. 2. For the parent 1. Having cognitive impairment at a level that prevents participation in the study 2. Not living in the same household with the child.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Haliç University Istanbul Eyup

Sponsors (1)

Lead Sponsor Collaborator
Halic University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Modified shuttle walk test (MST) Functional capacity only baseline
Secondary Forced expiratory volume at one second (FEV1) It is being evaluated to assess lung function. A spirometry is used for the assessment. only baseline
Secondary Forced vital capacity (FVC) It is being evaluated to assess lung function. A spirometry is used for the assessment. only baseline
Secondary Forced expiratory volume at one second / Forced vital capacity rate (FEV1/FVC) It is being evaluated to assess lung function. A spirometry is used for the assessment. only baseline
Secondary Peak expiratory flow (PEF) It is being evaluated to assess lung function. A spirometry is used for the assessment. only baseline
Secondary Maximum inspiratory pressure (MIP) It is being evaluated to assess inspiratory muscle strength. A intraoral pressure meter device is used for the assessment. only baseline
Secondary Maximum expiratory pressure (MEP) It is being evaluated to assess expiratory muscle strength. A intraoral pressure meter device is used for the assessment. only baseline
Secondary Physical Activity Questionnaire for Children (PAQ-C) The PAQ-C is a scale that assesses moderate to vigorous physical activity over the past seven days. For each item of the questionnaire, except for the tenth question that inquires about the disease status, an evaluation is made on a 5-point scale and an activity score between 1-5 is found. After the scores of the answers given to the nine questions are summed and divided by the number of questions, the score obtained is the total physical activity score of the child from the questionnaire. An average score of "1" indicates a low level of physical activity, while an average score of "5" indicates high physical activity. only baseline
Secondary Munich physical fitness test (MFT) The test consists of six parameters: ball bounce, target catch, forward bending, vertical jump, hang and step test. With this test, peer comparison according to age and gender and interpretation of motor performance can be made with objective scores. The total fitness score is the average of the six parameter scores. Physical fitness is classified as inadequate (=35), normal (36-45), adequate (46-55), good (56-65) or very good (=66) according to the total score. only baseline
Secondary Quadriceps strength It is being evaluated to assess quadriceps muscle strength. A hand-held dynamometer is used for the assessment. only baseline
Secondary Handgrip strength It is being evaluated to assess handgrip strength. A hand dynamometer is used for the assessment. only baseline
Secondary Cystic Fibrosis Questionnaire Revised (CFQ-R) The CFQ-R assesses quality of life. The CFQ-R is a cystic fibrosis-specific scale developed separately for both the child and the parent. Both versions are used in this study. The child version of the questionnaire consists of 35 items and the parent version consists of 50 items. Scores for each HRQoL domain; after recoding, each item is summed to generate a domain score and standardized. Scores range from 0 to 100, with higher scores indicating better health. CD-Rom Program available for scoring the CFQ-R. only baseline
Secondary Parental Attitude Scale (PAS) The PAS was developed to measure parents' child-rearing attitudes. Democratic (17 items), Authoritarian (11 items), Overprotective (9 items), Permissive (9 items). In scoring, scores and corresponding responses were 5 for "always", 4 for "most of the time", 3 for "sometimes", 2 for "rarely" and 1 for "never". Having a high score meant to adopt the behavior style represented by that domain. only baseline
Secondary Parent Attitude Scale The scale has three sub-dimensions: acceptance/affection, control/supervision and psychological autonomy. Accordingly, since the scale is scored as Always 5; Mostly 4; No opinion 3; Occasionally 2; Never 1, the individual to whom the scale is applied receives a minimum score of 15 and a maximum score of 75 from each dimension separately. Each dimension is evaluated according to whether the scores are low or high. In whichever dimension the score is higher, it is accepted that the child perceives parental attitude in that way. only baseline
Secondary Perceived Social Support Scale (PSS) PSS was developed to measure the social support perceived by children. The scale includes 5 items on social support perceived from mother and 5 items on social support perceived from father, and 4 items on social support perceived from peers. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. As the total score increases, the child's perception of social support increases. only baseline
Secondary Breathlessness Beliefs Questionnaire (BBQ) The questionnaire was developed based on the Tampa Kinesiophobia Scale to assess patients' dysfunctional beliefs about dyspnea due to reduced physical activity. The items question the patient's beliefs about the effects of dyspnea and whether activity should be avoided. The questionnaire has a minimum score of 11 and a maximum score of 55. As the total score increases, the belief in dysfunctional dyspnea increases. only baseline
See also
  Status Clinical Trial Phase
Completed NCT04696198 - Thoracic Mobility in Cystic Fibrosis Care N/A
Completed NCT00803205 - Study of Ataluren (PTC124™) in Cystic Fibrosis Phase 3
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03601637 - Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del Phase 3
Terminated NCT02769637 - Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
Recruiting NCT06012084 - The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis N/A
Recruiting NCT06032273 - Lung Transplant READY CF 2: CARING CF Ancillary RCT N/A
Recruiting NCT06030206 - Lung Transplant READY CF 2: A Multi-site RCT N/A
Recruiting NCT05392855 - Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF) N/A
Recruiting NCT06088485 - The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
Recruiting NCT04039087 - Sildenafil Exercise: Role of PDE5 Inhibition Phase 2/Phase 3
Recruiting NCT04056702 - Impact of Triple Combination CFTR Therapy on Sinus Disease.
Completed NCT04058548 - Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation N/A
Completed NCT04038710 - Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
Completed NCT03637504 - Feasibility of a Mobile Medication Plan Application in CF Patient Care N/A
Recruiting NCT03506061 - Trikafta in Cystic Fibrosis Patients Phase 2
Completed NCT03566550 - Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Completed NCT04568980 - Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
Recruiting NCT04010253 - Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis N/A